Brief: Simcere Pharmaceutical Says Regular Approval Of Xiannuoxin Approved By NMPA
11/07/2024 02:35
July 11 (Reuters) - Simcere Pharmaceutical Group Ltd
2096.HK :
* REGULAR APPROVAL OF XIANNUOXIN APPROVED BY NATIONAL
MEDICAL
PRODUCTS ADMINISTRATION
Further company coverage: 2096.HK
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660